Search

Your search keyword '"De Riva, Carlo"' showing total 11 results
Start Over Author "De Riva, Carlo"
11 results on '"De Riva, Carlo"'

1. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study

Author

Gabellieri, Enrico, Tortato, Elena, Rabini, Rosa Anna, Crazzolara, Dalia, Lucibelli, Luigi, Aragiusto, Concetta, Panzolato, Gianluigi, Di Mauro, Maurizio, Del Buono, Andrea, Placentino, Giuseppe, Di Cianni, Graziano, Brandoni, Gabriele, Fazion, Stefano, Gregori, Giovanna, Di Benedetto, Antonino, De Riva, Carlo, Terracciano, Annamaria, Zenari, Luciano, Cavalot, Franco, Porcellati, Francesca, Anichini, Roberto, Citro, Giuseppe, D'Angelo, Paola, Arca, Marcello, Morviducci, Lelio, Montani, Valeria, Fiorentini, Paolo, Candido, Riccardo, Nicolucci, Antonio, Larosa, Monica, Rossi, Maria Chiara, and Napoli, Raffaele

Published
2024
Full Text
View/download PDF

2. Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study

Author

Gabellieri, Enrico, Tortato, Elena, Rabini, Rosa Anna, Crazzolara, Dalia, Lucibelli, Luigi, Aragiusto, Concetta, Panzolato, Gianluigi, Di Mauro, Maurizio, Del Buono, Andrea, Placentino, Giuseppe, Di Cianni, Graziano, Brandoni, Gabriele, Fazion, Stefano, Gregori, Giovanna, Di Benedetto, Antonino, De Riva, Carlo, Terracciano, Annamaria, Napoli, Raffaele, Zenari, Luciano, Cavalot, Franco, Porcellati, Francesca, Anichini, Roberto, Citro, Giuseppe, D'Angelo, Paola, Arca, Marcello, Morviducci, Lelio, Montani, Valeria, Fiorentini, Paolo, Candido, Riccardo, Nicolucci, Antonio, Larosa, Monica, and Rossi, Maria Chiara

Published
2023
Full Text
View/download PDF

3. Treatment intensification following glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE‐G real‐world study.

Author

Napoli, Raffaele, Nicolucci, Antonio, Larosa, Monica, Rossi, Maria Chiara, Candido, Riccardo, Aragiusto, Concetta, Arca, Marcello, Anichini, Roberto, Brandoni, Gabriele, Cavalot, Franco, Citro, Giuseppe, Crazzolara, Dalia, D'Angelo, Paola, Del Buono, Andrea, De Riva, Carlo, Di Benedetto, Antonino, Di Cianni, Graziano, Di Mauro, Maurizio, Fazion, Stefano, and Fiorentini, Paolo

Subjects
TYPE 2 diabetes, INSULIN receptors, PROPENSITY score matching, ELECTRONIC health records, BLOOD sugar
Abstract

Aim: To compare the effectiveness of different basal insulins (BI) prescribed as an add‐on to or switch from glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) therapy. Materials and Methods: Retrospective, real‐world data from electronic medical records of 32 Italian diabetes clinics were used, after propensity score adjustment, to compare effectiveness after 6 months of treatment with second‐ versus first‐generation BI (2BI vs. 1BI) or glargine 300 U/ml versus degludec 100 U/ml (Gla‐300 vs. Deg‐100), when added to (ADD‐ON) or in substitution of (SWITCH) GLP‐1 RA. Only comparisons, including a minimum of 100 patients per group, were performed to ensure adequate robustness of the analyses. Results: In the ADD‐ON cohort (N = 700), greater benefits of 2BI versus 1BI were found in glycated haemoglobin {HbA1c; estimated mean difference: −0.32% [95% confidence interval (CI) −0.62; −0.02]; p =.04} and fasting blood glucose [FBG; −20.73 mg/dl (95% CI −35.62; −5.84); p =.007]. In the SWITCH cohort (N = 2097), greater benefits of 2BI versus 1BI were found in HbA1c [−0.22% (95% CI −0.42; −0.02); p =.03], FBG [−10.15 mg/dl (95% CI −19.04; −1.26); p =.03], and body weight [−0.67 kg (95% CI −1.30; −0.04); p =.04]. In the SWITCH cohort starting 2BI (N = 688), marked differences in favour of Gla‐300 versus Deg‐100 were documented in HbA1c [−0.89% (95% CI −1.26; −0.52); p <.001] and FBG [−17.89 mg/dl (95% CI −32.45; −3.33); p =.02]. Using propensity score matching as a sensitivity analysis, the benefit on HbA1c was confirmed [−0.55% (95% CI –1.02; −0.08); p =.02]. BI titration was suboptimal in all examined cohorts. Conclusions: 2BI are a valuable option to intensify GLP‐1 RA therapy. Switching to Gla‐300 versus Deg‐100 was associated with greater HbA1c improvement. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Treatment Intensification following Glucagon-Like Peptide-1 Receptor Agonist Treatment in Type 2 Diabetes: the RESTORE-G Real-World Study

Author

Candido, Riccardo, primary, Nicolucci, Antonio, additional, Larosa, Monica, additional, Rossi, Maria Chiara, additional, Napoli, Raffaele, additional, Gabellieri, Enrico, additional, Tortato, Elena, additional, Rabini, Rosa Anna, additional, Lucibelli, Luigi, additional, Aragiusto, Concetta, additional, Panzolato, Gianluigi, additional, Di Mauro, Maurizio, additional, Del Buono, Andrea, additional, Placentino, Giuseppe, additional, Brandoni, Gabriele, additional, Fazion, Stefano, additional, Gregori, Giovanna, additional, Di Benedetto, Antonino, additional, De Riva, Carlo, additional, Terracciano, Annamaria, additional, Cavalot, Franco, additional, Anichini, Roberto, additional, Citro, Giuseppe, additional, D'Angelo, Paola, additional, Arca, Marcello, additional, Morviducci, Lelio, additional, Montani, Valeria, additional, and Porcellati, Francesca, additional

Published
2023
Full Text
View/download PDF

6. Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Author

Solerte, Sebastiano Bruno, primary, D’Addio, Francesca, additional, Trevisan, Roberto, additional, Lovati, Elisabetta, additional, Rossi, Antonio, additional, Pastore, Ida, additional, Dell’Acqua, Marco, additional, Ippolito, Elio, additional, Scaranna, Cristiana, additional, Bellante, Rosalia, additional, Galliani, Silvia, additional, Dodesini, Alessandro Roberto, additional, Lepore, Giuseppe, additional, Geni, Francesca, additional, Fiorina, Roberta Maria, additional, Catena, Emanuele, additional, Corsico, Angelo, additional, Colombo, Riccardo, additional, Mirani, Marco, additional, De Riva, Carlo, additional, Oleandri, Salvatore Endrio, additional, Abdi, Reza, additional, Bonventre, Joseph V., additional, Rusconi, Stefano, additional, Folli, Franco, additional, Di Sabatino, Antonio, additional, Zuccotti, Gianvincenzo, additional, Galli, Massimo, additional, and Fiorina, Paolo, additional

Published
2020
Full Text
View/download PDF

7. Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats

Author

Perico, Norberto, Benigni, Ariela, Gabanelli, Maurizio, Piccinelli, Antonella, Rog, Marek, De Riva, Carlo, and Remuzzi, Giuseppe

Subjects
Diabetes -- Physiological aspects, Natriuretic peptides -- Physiological aspects, Prostacyclin -- Physiological aspects, Health, Physiological aspects
Abstract

Hyperfiltration and hyperperfusion in diabetes mellitus have been convincingly associated with the progression of the disease (1). Thus, extensive research has tried to clarify the mechanism that underlies the hyperfiltration [...]

Published
1992

8. Area of admission and short-term care: an integral part of the internal medicine ward organized to intensive care

Author

Serafini, Francesco, primary, Bonanni, Luca, primary, Zancanaro, Andrea, primary, Fricano, Giuseppina, primary, Giannoccaro, Marco, primary, Zulian, Elisa, primary, Dalla Vestra, Michele, primary, Atanasio, Paola, primary, Conton, Pierantonio, primary, De Riva, Carlo, primary, Fantin, Giuseppe, primary, and Presotto, Fabio, primary

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results